Brief: Rubius Therapeutics To Acquire Manufacturing Facility In Smithfield, Rhode Island
25/07/2018 13:49
July 25 (Reuters) - Rubius Therapeutics Inc RUBY.O :
* RUBIUS THERAPEUTICS TO ACQUIRE MANUFACTURING FACILITY IN
SMITHFIELD, RHODE ISLAND TO PRODUCE RED CELL THERAPEUTICS
* RUBIUS THERAPEUTICS INC - COMPANY PLANS TO INVEST UP TO
$95
MILLION THROUGH 2020
* RUBIUS THERAPEUTICS INC - COMPANY PLANS TO INVEST UP TO
$95
MILLION THROUGH 2020, AND UP TO $155 MILLION IN TOTAL OVER A
FIVE-PLUS YEAR PERIOD
Source text for Eikon: ID:nGNX5j4g7d
Further company coverage: RUBY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rubius Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Apple, TCR2 Therapeutics, Silvergate Capital
Brief: Rubius Therapeutics Inc - Nasdaq Notified Co That Trading In Co's Stock Will Be Suspended Upon Opening Of Business On March 7, 2023
Brief: Rubius Therapeutics Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Rubius Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Baidu, Boeing, Microsoft